This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Consiglio Nazionale Delle Ricerche, Universita' Degli Studi Di Pisa, Universita′ Degli Studi Di Milano. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 327 
1 out of 3 
1 out of 40 Years Active: 2012
Title: Maria Letizia Trincavelli: Innovator in Neuroprotective Compounds
Introduction
Maria Letizia Trincavelli is an accomplished inventor based in Pisa, Italy. She is currently affiliated with Centro Cardiologico Monzino S.p.a. Despite having no granted patents, her contributions to the field of neuroprotective compounds are noteworthy. She collaborates with esteemed colleagues such as Mariapia Abbracchio and Ivano Eberini.
Latest Patent Applications
Maria Letizia Trincavelli's latest patent applications include "GPR17-MODULATING COMPOUNDS, DIAGNOSTIC AND THERAPEUTIC USES THEREOF." This application discloses compounds that can modulate the activity of the GPR17 receptor in a highly specific manner. These compounds are useful in the treatment and diagnosis of diseases or dysfunctions involving the activation of the GPR17 receptor. In particular, they can be utilized for neuroprotective and reparatory purposes in conditions such as cerebral, cardiac, and renal ischemia, as well as in cerebral trauma and chronic neurodegenerative diseases like amyotrophic lateral sclerosis (ALS) and demyelinating diseases such as multiple sclerosis.
Conclusion
Maria Letizia Trincavelli is making significant strides in the field of neuroprotective research, showcasing her innovative spirit through her latest patent applications. Her work holds promise for advancing treatments in critical health areas.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile